These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28395743)
21. Generation of induced pluripotent stem cell line from foreskin fibroblasts. Skrzypczyk A; Giri S; Bader A Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413 [TBL] [Abstract][Full Text] [Related]
22. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder. Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401 [TBL] [Abstract][Full Text] [Related]
23. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female. Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589 [TBL] [Abstract][Full Text] [Related]
24. Generation and characterization of two iPSC lines from human epicardium-derived cells. Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740 [TBL] [Abstract][Full Text] [Related]
25. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803 [TBL] [Abstract][Full Text] [Related]
26. Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders. Hinz L; Hoekstra SD; Watanabe K; Posthuma D; Heine VM Stem Cell Rev Rep; 2019 Apr; 15(2):276-285. PubMed ID: 30421281 [TBL] [Abstract][Full Text] [Related]
27. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A. Lach MS; Wroblewska JP; Augustyniak E; Kulcenty K; Suchorska WM Stem Cell Res; 2017 Apr; 20():34-37. PubMed ID: 28395738 [TBL] [Abstract][Full Text] [Related]
28. Generation of human induced pluripotent stem cell lines derived from four Rett syndrome patients with MECP2 mutations. Mori M; Yoshii S; Noguchi M; Takagi D; Shimizu T; Ito H; Matsuo-Takasaki M; Nakamura Y; Takahashi S; Hamada H; Ohnuma K; Shiohama T; Hayashi Y Stem Cell Res; 2024 Jun; 77():103432. PubMed ID: 38703668 [TBL] [Abstract][Full Text] [Related]
29. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors. Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906 [TBL] [Abstract][Full Text] [Related]
30. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7. Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592 [TBL] [Abstract][Full Text] [Related]
31. Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions. Uhlin E; Rönnholm H; Day K; Kele M; Tammimies K; Bölte S; Falk A Stem Cell Res; 2017 Jan; 18():22-25. PubMed ID: 28395796 [TBL] [Abstract][Full Text] [Related]
33. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Kim KY; Hysolli E; Park IH Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14169-74. PubMed ID: 21807996 [TBL] [Abstract][Full Text] [Related]
34. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984. Zulfiqar S; Fritz B; Nieweg K Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402 [TBL] [Abstract][Full Text] [Related]
35. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells Using Auto-Erasable Sendai Virus Vector. Tsukamoto M; Nishimura T; Yodoe K; Kanegi R; Tsujimoto Y; Alam ME; Kuramochi M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Inaba T; Sugiura K; Hatoya S Stem Cells Dev; 2018 Nov; 27(22):1577-1586. PubMed ID: 30215317 [TBL] [Abstract][Full Text] [Related]
36. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene. Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795 [TBL] [Abstract][Full Text] [Related]
37. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672 [TBL] [Abstract][Full Text] [Related]
38. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. Ananiev G; Williams EC; Li H; Chang Q PLoS One; 2011; 6(9):e25255. PubMed ID: 21966470 [TBL] [Abstract][Full Text] [Related]
39. Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene. Itoh M; Kawagoe S; Okano HJ; Nakagawa H Stem Cell Res; 2016 May; 16(3):611-3. PubMed ID: 27346194 [TBL] [Abstract][Full Text] [Related]
40. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation. Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]